Title:
小細胞肺がんおよびその他のがんに対する免疫療法で使用するためのペプチドおよびペプチド組み合わせ
Document Type and Number:
Japanese Patent JP7344917
Kind Code:
B2
Abstract:
The present invention relates to peptides, proteins, nucleic acids and cells for use in immunotherapeutic methods. In particular, the present invention relates to the immunotherapy of cancer. The present invention furthermore relates to tumor-associated T-cell peptide epitopes, alone or in combination with other tumor-associated peptides that can for example serve as active pharmaceutical ingredients of vaccine compositions that stimulate anti-tumor immune responses, or to stimulate T cells ex vivo and transfer into patients. Peptides bound to molecules of the major histocompatibility complex (MHC), or peptides as such, can also be targets of antibodies, soluble T-cell receptors, and other binding molecules.
Inventors:
Andrea, Mare
Weinschenk, Toni
Goldfinger, Valentina
Shall, Oliver
Fritche, jens
Shin, Harpreet
Weinschenk, Toni
Goldfinger, Valentina
Shall, Oliver
Fritche, jens
Shin, Harpreet
Application Number:
JP2021047882A
Publication Date:
September 14, 2023
Filing Date:
March 22, 2021
Export Citation:
Assignee:
Immatics Biotechnology Gem Beher
International Classes:
C12N15/12; A61K31/7088; A61K35/15; A61K35/17; A61K38/08; A61K38/17; A61K39/00; A61K39/395; A61K48/00; A61P35/00; C07K7/06; C07K14/725; C07K16/18; C12N5/0783; C12N5/0784; C12N5/10; C12N15/115; C12N15/13; C12N15/63; C12P21/02
Domestic Patent References:
| JP2014507138A | ||||
| JP2021119773A | ||||
| JP2021126114A |
Foreign References:
| WO2015018805A1 |
Other References:
Jiang, H. et al.,"Knockdown of hMex-3A by small RNA interference suppresses cell proliferation and migration in human gastric cancer cells",Mol. Med. Rep.,2012年,Vol. 6,pp. 575-580
Attorney, Agent or Firm:
Go Akatsu